Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant modified vaccinia Ankara expressing human 5T4

EU orphan designation number: EU/3/06/429   
Active ingredient: Recombinant modified vaccinia Ankara expressing human 5T4
Indication: Treatment of renal cell carcinoma
Sponsor: Oxford Biomedica (UK) Ltd
The Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford, OX4 4GA, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2007 Centralised Orphan - Designation EMEA/OD/084/06 (2007)319 of 26/01/2007
20/02/2007 Corrigendum (2007)319 of 05/03/2007